Muhammad Bilal Abid
Overview
Explore the profile of Muhammad Bilal Abid including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
802
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nath K, Zhang M, Bye M, Abid M, Benjamin C, Betts B, et al.
Blood Adv
. 2025 Mar;
PMID: 40048743
Whether younger donors should be prioritized over HLA-matching for allogeneic hematopoietic cell transplantation (allo-HCT) when using post-transplant cyclophosphamide (PTCy)-based graft versus host disease (GvHD) prophylaxis is unclear. To address this,...
2.
Treon S, Kotton C, Park D, Moranzoni G, Lemvigh C, Gathe Jr J, et al.
Front Immunol
. 2025 Feb;
15:1369619.
PMID: 39906744
Background: Cytokine release triggered by a hyperactive immune response is thought to contribute to severe acute respiratory syndrome coronavirus 2019 (SARS-CoV-2)-related respiratory failure. Bruton tyrosine kinase (BTK) is involved in...
3.
Cherie T, Choong C, Abid M, Weber M, Yap E, Seneviratne S, et al.
Viruses
. 2024 Jul;
16(7).
PMID: 39066252
Dengue infection is caused by the dengue virus (DENV) and is transmitted to humans by infected female and mosquitoes. There are nearly 100 million new dengue cases yearly in more...
4.
Kim M, Arabi J, McCoy C, DSouza A, Chhabra S, Abid M, et al.
Clin Lymphoma Myeloma Leuk
. 2024 Jul;
24(11):804-807.
PMID: 39043500
No abstract available.
5.
Ballen K, Wang T, He N, Knight J, Hong S, Frangoul H, et al.
Transplant Cell Ther
. 2024 Jul;
30(10):1027.e1-1027.e14.
PMID: 39033978
Background: Umbilical cord blood transplant (UCBT) improves access to transplant for patients lacking a fully matched donor. Previous Center for International Blood and Marrow Transplant Research (CIBMTR) showed that Black...
6.
Gonugunta A, Mohlere V, Abid M
Br J Haematol
. 2024 Jul;
205(3):1197-1201.
PMID: 38981510
No abstract available.
7.
Khera N, Ailawadhi S, Brazauskas R, Patel J, Jacobs B, Ustun C, et al.
Blood Adv
. 2024 Apr;
8(13):3497-3506.
PMID: 38661372
There has been an increase in volume as well as an improvement in overall survival (OS) after hematopoietic cell transplantation (HCT) for hematologic disorders. It is unknown if these changes...
8.
Locke F, Siddiqi T, Jacobson C, Ghobadi A, Ahmed S, Miklos D, et al.
Blood
. 2024 Apr;
143(26):2722-2734.
PMID: 38635762
Axicabtagene ciloleucel (axi-cel) is an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy approved for relapsed/refractory (R/R) large B-cell lymphoma (LBCL). Despite extensive data supporting its use, outcomes stratified by...
9.
Rubin M, Suelzer E, Ulschmid C, Thapa B, Szabo A, Abid M
Asian Pac J Cancer Prev
. 2024 Feb;
25(2):393-399.
PMID: 38415523
Objective: Recipients of allogeneic hematopoietic cell transplantation (alloHCT) are at increased risk of morbidity and mortality due to COVID-19. Immune responses to SARS-CoV-2 vaccines are blunted in these profoundly immunocompromised...
10.
Abid M, Rubin M, Szabo A, Longo W, Fenske T, McCoy C, et al.
Transplant Cell Ther
. 2023 Dec;
30(3):285-297.
PMID: 38142942
The mortality due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) approaches 40% in recipients of chimeric antigen receptor (CAR) T cell therapy (CAR-T). The efficacy of repeated vaccine doses,...